Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia

Indian Heart Journal

Volumn 48, Issue 2, 1996, Pages 133-137

  Gambhir, D S ^a   Bhargava, M ^a   Nair, M ^a   Arora, R ^a   Khalilullah, M ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; TACHYCARDIA;

ADMINISTRATION, ORAL; ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECURRENCE; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY;

EID: 0029943302     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Andreson F, Agerback H, Bjerregaard P, et al. Pharmcokinetics of amiodarone after intravenous and oral administration. Euro J Clin Pharmacol 1981; 19: 293-299
2. Wellens HJJ, Brugada P, Abdollah H, et al. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Circulation 1984; 69: 120-124
3. Kadish AH, Marchlinski FE, Josephson ME, et al. Amiodarone: Correlation of early and late electrophysiologic studies with outcome. Am Heart J 1986; 112: 1134-1140
4. Kopelman HA, Horowitz LN. Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias. Prog Cardiovasc Dis 1989; 31: 355-366
5. Storelli A, Hndriulo C, Chisena H, et al Intravenous amiodarone in the therapy of paroxysmal supraventricular tachycardias. G Ital Cardiol 1985, 15: 290-297
6. Gomes JAC, Kand PS, Haroman RJ, et al. Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone Am Heart J 1984; 107: 214-221
7. Alboni P, Shantha N, Pirani R, et al. Effects of amiodarone on supraventricular tachycardia involving bypass tracts. Am J Cardiol 1984, 53. 93-98
8. Ikeda N, Nademanee K, Kannan R, et al. Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J 1984; 108. 890-898
9. Morady F, DiCarlo LA, Baerman JM, et al. Rate dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction. J Am Coll Cardiol 1985; 6: 179-185
10. Waleffe A, Bruninx P, Kulbertus H. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal reentrant supraventricular tachycardia. J Electrocardiol 1978; 11: 253-260
11. Talajic M, De Roode MR, Nattel S. Comparative electrophysiologic effects of intravenous amiodarone and desethyl amiodarone in dogs. Evidence for clinically relevant activity of the metabolite. Circulation 1987; 75 265-271
12. Podrid PJ, Lown B. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. Am Heart J 1981; 101: 374-379
13. Yabek SM, Kato R, Singh BN. Effects of amiodarone and its metabolite, desethyl amiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol 1986; 8: 197-207
14. Bacq ZM, Biakeley GM, Summers RJ. The effects of amiodarone on alpha and beta receptor antagonist, on adrenergic transmission in the cat spleen Biochem Pharmacol 1976; 25. 1195-1199
15. Polster P, Brockhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol 1976, 25. 131-134